For more information about products within the Pathway Portfolio, please click here for prescribing information
For more information about products within the Pathway Portfolio, please click here for prescribing information
Indicated for the symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder syndrome4.
Neditol® XL is the market leader for prolonged release tolterodine tartrate capsules1.
Neditol® XL is the market leader for prolonged release tolterodine tartrate, as such Neditol® XL is the same price as the UK drug tariff3.
References:
*Average ICS is based on 4 x Moving Quarterly Turnover (MQT) divided by 42 ICS/ICB’s
XLW1010311E2_OCT2024